SUMMARY The effect of acute oral administration of three different doses (4, 8, and 16 Loperamide is a new opiate constipating agent, now widely used in the treatment of diarrhoea.7 The drug strongly inhibits gastrointestinal motility, an effect qualitatively similar to that exhibited by morphine and completely blocked by naloxone.8
The effects of opiates on gastric secretion have recently been investigated. In man, both morphine and naloxone have been demonstrated to inhibit basal and meal-stimulated gastric acid secretion. ' Meperidine, another drug with opiate receptorstimulating properties, has been shown potently to reduce basal gastric acid secretion.2 In dogs, both morphine and met-enkephalin have been reported to enhance basal3-5 as well as histamine-stimulated4 5 gastric acid secretion. Conflicting results have been obtained after vagal and pentagastrin stimulation, as Magee4 reported that morphine inhibits both vagally and pentagastrin-stimulated gastric secretion, while a dose-dependent augmentation of pentagastrin-induced acid secretion by morphine and met-enkephalin was observed by Konturek et al., an Loperamide, unlike the other opiates,9 "' does not cross the blood-brain barrier. l l
The aim of the present study was to evaluate the effect of loperamide alone, naloxone alone, and of a combination of the two drugs, on basal and submaximal pentagastrin-stimulated gastric acid secretion in healthy man.
Methods
Thirty-seven healthy subjects who had no history of gastrointestinal diseases volunteered for the study. There were 17 women and 20 men, aged 21-55 years (mean, 42 years 
